SANKYO CO., LTD.

Transcripts Sankyo Co., Ltd.

Equities

6417

JP3326410002

Delayed Japan Exchange Other stock markets 10:08:26 2024-04-29 pm EDT			5-day change	1st Jan Change
1,720 ^JPY	+3.40%		+4.30%	+4.65%

Apr. 29	AstraZeneca makes progress with Truqap and Enhertu cancer treatments	AN
Apr. 25	AstraZeneca upbeat as cancer drugs underpin sales growth	AN

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sankyo Co., Ltd. Provides Financial Guidance for the Year Ending March 31, 2023	22-08-04	CI
Sankyo Co., Ltd. Provides Financial Guidance for the Year Ending March 31, 2023	22-05-12	CI
Sankyo Co., Ltd. Provides Financial Guidance for the Year Ending March 31, 2022	21-11-08	CI
Sankyo Co., Ltd. Provides Earnings Forecast for the Year Ending March 31, 2022	21-08-05	CI
Sankyo Co., Ltd. Provides Earnings Guidance for the Year Ending March 31, 2022	21-05-13	CI
Sankyo Co., Ltd. Provides Earnings Guidance for the Year Ending March 31, 2021	21-02-08	CI
Sankyo Co., Ltd. Provides Earnings Guidance for the Full Year Ending March 31, 2021	20-11-09	CI
Sankyo Co., Ltd. Provides Earnings Guidance for the Year Ending March 31, 2021	20-08-07	CI
Sankyo Co., Ltd. Announces Consolidated Earnings Results for the First Quarter Ended June 30, 2016; Provides Earnings Guidance for the Full Year Ending March 31, 2017	16-08-04	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

As early as today, start finding the best investment opportunities!

Optimize my profits

fermer